| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Scott Schlackman is Director at MED. Scott Schlackman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $532K at current prices.
Historically, Scott Schlackman's trades have earned a middling insider score of 62/100 across 10 rated trades. Over a 12-month horizon, 37.5% of those trades were profitable, with an average 12-month return of -17.4%.
The MED filings lean toward selling, a net 9,746 shares.
Scott Schlackman has 25 Form 4 filings on record from September 2015 to May 2026, all as Director at Medifast (MED), 2015–2026.
The 36 reported transactions were 13 stock awards, 10 open-market sales, 7 open-market purchases and 4 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 6 purchases worth about $74K and 6 sales worth about $1.6M.
The largest open-market purchase was 5,000 shares of MED at an average $12.59 on May 11, 2026, about $63K.
The largest open-market sale was 3,119 shares of MED at an average $107.55 on June 4, 2020, about $335K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | MED Medifast, Inc. | Director | Buy | 5,000 | $12.59 | $62,950.00 | +19.6% | -2.5% | - | |
| Mar 8, 2024 | MED Medifast Inc | Director | Sale+OE | 4,053 | $39.44 | $159,866.38 | -34.2% | -44.9% | -63.6% | |
| Nov 7, 2023 | MED Medifast Inc | Director | Buy | 53 | $68.89 | $3,626.78 | +0.5% | -25.0% | -71.4% | |
| Aug 8, 2023 | MED Medifast Inc | Director | Buy | 40 | $89.42 | $3,561.06 | +0.4% | -21.0% | -77.7% | |
| May 9, 2023 | MED Medifast Inc | Director | Buy | 13 | $87.50 | $1,150.19 | +0.2% | +9.8% | -71.5% | |
| Mar 10, 2023 | MED Medifast Inc | Director | Sale+OE | 2,200 | $108.68 | $239,096.00 | -23.2% | -23.3% | -62.9% | |
| Feb 7, 2023 | MED Medifast Inc | Director | Buy | 10 | $114.97 | $1,127.17 | +0.1% | -22.0% | -53.0% | |
| Nov 8, 2022 | MED Medifast Inc | Director | Buy | 10 | $106.93 | $1,110.15 | +0.1% | +3.9% | -38.9% | |
| May 19, 2021 | MED Medifast Inc | Director | Sell | 1,000 | $310.23 | $310,232.08 | -16.3% | -27.8% | -47.0% | |
| Jun 4, 2020 | MED Medifast Inc | Director | Sale+OE | 3,119 | $107.55 | $335,454.65 | -41.3% | - | - |